Stockreport

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF Company focused on advancing next-generation anti-cancer therapies derived from well-established drug classes, now engineered to cross the blood-brain barrier, potentia [Read more]